US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

Business leaders from major Hoosier companies say they are trying to navigate the uncertain trade environment created by ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

The package revives President Donald Trump’s much-maligned Most Favored Nation rule but goes further into the private markets ...

Announcement pressures pharma stocks on worries profits will be hit if they have to cut prices in US. Read more at ...

Trump’s drug pricing order sparks global pharma sell-off as industry warns of stifled innovation and revenue loss in key US ...

Eli Lil­ly is set to pay up to $415 million in an ALS deal ... Takeda pledged $30 billion in U.S. manufacturing and argued against President Donald Trump’s ‘most favored nations’ proposal. Gilead ...

By Sriparna Roy and Joel Jose (Reuters) -Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts ...

Shares of pharmaceutical companies fell across the world after US President Donald Trump said he planned to order a cut in US ...

President Donald Trump's second term in office has been challenging for investors, at least so far. Trump imposed sweeping ...

INDIANAPOLIS — Over the next eight years, Eli Lilly and Company and Purdue ... America’s Hard Tech Corridor. We thank Lilly for its pioneering impact on health and medicine in our society ...